Century Therapeutics CSO Chad Cowan moves to part-time with reduced salary

Century Therapeutics, Inc.

Chad Cowan continues as CSO on part-time basis; salary cut to $296,150 annually.
Eligible for pro-rated annual performance-based target bonus.
Upon company termination or resignation, entitled only to accrued unpaid base salary.
A&R Employment Agreement to be filed as exhibit to Q2 2026 10-Q.
Agreement effective June 15, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.